FDA Webview Site FDA Review Site FDA Updater Site
header.gif
Username:
Password:
 

human drugs
animal drugs
biologics
eirs 483s
medical devices
marketing
email
search our site
  
FDA-RELATED NEWS
 
 
 
TXT FDA Dims LASIK Harms it Found in ‘Life Quality’ Study [717 Words]
10/20/2014
 
 
TXT Petition Seeks OTC Switch for Oral Contraceptives [270 Words]
10/23/2014
 
 
TXT FDA Group Sets Base for Breast Cancer Master Protocol [1197 Words]
10/23/2014
 
 
TXT CDER Already Surpasses NME Approval Totals for Last Year [18316 Words]
10/20/2014
 
 
TXT Don’t Let 510(k) Guidance Become ‘Back Door’: MDMA [254 Words]
10/23/2014
 
 
TXT ‘Regulatory Creep’ Seen in FDA Inspection Guidance [452 Words]
10/23/2014
 
 
TXT Withdraw Distribution of Scientific Info Guide: Public Citizen [304 Words]
10/22/2014
 
 
TXT FDA Computer Network Vulnerable: OIG [348 Words]
10/21/2014
 
 
TXT FDA Guide on Delaying, Denying Drug Inspections [224 Words]
10/21/2014
 
 
TXT Drug Companies Sharing Trial Data with Researchers [392 Words]
10/23/2014
 
 
TXT Too Soon to Say if Device Review Process is Better: Report [367 Words]
10/23/2014
 
 
TXT Latest Federal Register Notices [1117 Words]
10/26/2014
 
 
TXT Since Our Last Issue ... [356 Words]
10/26/2014
 
 
TXT Product Approval Summaries [468 Words]
10/26/2014
 
 
TXT CBER Guide on ‘Same Surgical Procedure’ Under HCT/P Rule [144 Words]
10/24/2014
 
 
TXT FDA Warning Letter on Hikma Pharma’s Portugal Plant [284 Words]
10/24/2014
 
 
TXT Dallas Jury Clears J&J Unit in Hip Implant Case [141 Words]
10/24/2014
 
 
TXT Biogen Idec Confirms 1st PML Case with New Multiple Sclerosis Drug [257 Words]
10/23/2014
 
 
TXT FDA Supporting Online Rare Disease Study Tool [368 Words]
10/23/2014
 
 
TXT Teva Wants Generic QVAR to Have Dose Counter [203 Words]
10/23/2014
 
 
TXT Hamburg Touts FDA Rare Disease Efforts [342 Words]
10/22/2014
 
 
TXT Recalled Supplements Sell with Banned Ingredients: Study [2788 Words]
10/22/2014
 
 
TXT Court Says Some False Ad Claims Need FDA Expertise [317 Words]
10/22/2014
 
 
TXT Restrictions Sought on Generic Prepopik [322 Words]
10/22/2014
 
 
TXT Homeland Security Probing Device Cyber Flaws [280 Words]
10/22/2014
 
 
TXT FDA Guidance on Developing Drugs for Acute Migraine [364 Words]
10/21/2014
 
 
TXT Latest FDA Warning Letters [453 Words]
10/21/2014
 
 
TXT FDA Biomarker Letter of Support for Kidney Markers [280 Words]
10/21/2014
 
 
TXT QS Violations in Western/Scott Fetzer Inspection [414 Words]
10/21/2014
 
 
TXT Spectrum Pharma Petitions FDA to Block Fusilev Generics [141 Words]
10/20/2014
 
 
 
 
The most authoritative FDA news analysis each week is found in the pages of Dickinson's FDA Review. Since 1984, this newsletter has been providing in-depth reports on the most significant FDA developments affecting the pharmaceutical, medical device, biologics and veterinary medicines industries. Unlike other media, FDA Review eliminates time-wasting minutia and presents in clear, concise language the essence of what's really important - and why. It is the publication that FDA officials themselves read. Delivered in the middle of each week, FDA Review presents:
  • The latest agency policy developments, often before they're officially announced;
  • Major news insights, follow-ups and reactions in each product area;
  • Summaries of the latest Warning Letters;
  • The newest product approvals;
  • Summaries of the latest FDA Federal Register notices;
  • Summaries of DDMAC letters;
  • Related industry news capsules;
  • The industry's most concise FDA news index;
  • Inside-FDA news briefs
You can rely on FDA Review to provide only what's important - in the most convenient and time-saving